MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Primary_Xometry_Blue-svg
Xometry, Inc. (XMTR)
Primary_Xometry_Blue-svg
Xometry, Inc. (XMTR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$707K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Proceeds from issuance of common...
Proceeds from sale of marketable...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Capitalization of software devel...
Stock-based compensation
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Segment revenue
229,281
205,138
192,397
180,716
Segment cost of revenue
142,127
126,650
117,160
108,687
Segment adjusted operating expense
73,191
68,180
67,041
66,071
US
-181
-177
-186
-184
Non Us
0
0
-
0
Other segment items
-181
-177
-186
-184
Total adjusted ebitda
14,144
10,485
8,382
6,142
Interest expense, interest and dividend income and other expenses
-329
-63
-892
775
Depreciation and amortization
5,836
4,931
5,009
5,000
Amortization of lease intangible
0
0
180
180
(provision) benefit for income taxes
354
248
614
-17
Stock-based compensation
11,346
8,327
10,377
10,748
Payroll tax expense related to stock-based compensation
459
1,605
365
366
Acquisition and other
281
0
237
0
Charitable contribution of common stock
1,811
826
1,192
950
Income from unconsolidated joint venture
255
146
-140
220
Impairment of assets
-
-
0
49
Restructuring charges
-46
16
-202
-92
Net loss
-5,313
-5,259
-8,638
-11,597
Depreciation and amortization
5,836
4,931
5,009
5,000
Impairment of assets
-
-
0
49
Reduction in carrying amount of right-of-use asset
623
552
1,288
1,138
Lease termination
0
0
0
-16
Stock-based compensation
11,346
8,327
10,377
10,748
Revaluation of contingent consideration
-
-
0
0
Income from unconsolidated joint venture
15
86
-54
54
Donation of common stock
1,811
826
1,192
950
Loss on debt extinguishment
0
-
0
0
Loss on sale of property and equipment
-
-
0
0
Inventory write-off
-
-
0
-
Amortization of deferred costs on convertible notes
571
571
571
590
Deferred tax benefit
-12
-
-40
-21
Accounts receivable, net
10,650
22,664
-1,561
9,865
Inventory
296
-273
-327
-380
Prepaid expenses
1,149
-214
1,352
786
Other assets
3,243
3,113
-461
1,174
Accounts payable and accrued cost of revenue
8,001
17,657
-1,568
4,367
Other accrued expenses
-5,494
11,014
-1,660
7,106
Contract liabilities
1,502
1,761
-1,019
1,120
Lease liabilities
-590
-340
-1,690
-2,032
Other liabilities
1
-55
0
-2
Income taxes payable
-10
14
-461
-141
Net cash provided by (used in) operating activities
2,919
14,623
4,412
5,792
Purchases of marketable securities
314,491
12,280
1,971
2,133
Proceeds from sale of marketable securities
22,500
13,500
1,500
7,500
Purchases of property and equipment
-
-
10,269
7,449
Capitalization of software development and purchases of property and equipment
13,379
10,581
-
-
Distributions in excess of earnings
-40
40
20
-
Proceeds from sale of property and equipment
-
-
0
0
Cash paid for business combination, net of cash acquired
-
-
0
-
Net cash used in investing activities
-305,410
-9,321
-10,654
-2,148
Proceeds from issuance of convertible notes
0
-
0
0
Costs incurred in connection with issuance of convertible notes
0
-
0
828
Payments for repurchase of convertible notes
0
-
0
0
Purchase of capped calls
0
-
0
0
Purchase of treasury stock
0
-
0
0
Proceeds from stock options exercised
5,066
830
384
1,288
Proceeds from issuance of common stock, net of underwriters' discount
248,400
-
-
-
Payment of costs related to issuance of common stock
315
-
-
-
Payment of contingent consideration
-
-
0
-
Proceeds from issuance of common stock under siemens agreement
50,000
-
-
-
Net cash provided by financing activities
303,151
830
384
460
Effect of foreign currency translation on cash and cash equivalents
47
-82
9
-10
Net increase (decrease) in cash and cash equivalents
707
6,050
-5,849
4,094
Cash and cash equivalents at beginning of the period
21,046
14,996
15,507
15,507
Cash and cash equivalents at end of the period
21,753
21,046
14,996
20,845
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
XMTR Cash Flow Sankey Diagram
Sankey diagram visualizing XMTR cash flow for the period
US
-$181K
(1.63%↑ Y/Y)
Proceeds from issuance of
common stock, net of...
$248,400K
Proceeds from issuance of
common stock under...
$50,000K
Proceeds from stock
options exercised
$5,066K
(459.78%↑ Y/Y)
Stock-based compensation
$11,346K
(43.71%↑ Y/Y)
Accounts payable and
accrued cost of revenue
$8,001K
(192.10%↑ Y/Y)
Depreciation and
amortization
$5,836K
(29.83%↑ Y/Y)
Donation of common stock
$1,811K
(194.95%↑ Y/Y)
Contract liabilities
$1,502K
(768.21%↑ Y/Y)
Reduction in carrying
amount of right-of-use...
$623K
(-43.97%↓ Y/Y)
Amortization of deferred
costs on convertible...
$571K
(20.97%↑ Y/Y)
Other liabilities
$1K
(111.11%↑ Y/Y)
Segment revenue
$229,281K
(41.06%↑ Y/Y)
Other segment items
-$181K
(1.63%↑ Y/Y)
Net cash provided by
financing activities
$303,151K
(19636.39%↑ Y/Y)
Net cash provided by
(used in) operating...
$2,919K
(783.61%↑ Y/Y)
Effect of foreign
currency translation on...
$47K
(-83.39%↓ Y/Y)
Canceled cashflow
$315K
Canceled cashflow
$26,772K
Total adjusted ebitda
$14,144K
(260.26%↑ Y/Y)
Interest expense,
interest and dividend...
-$329K
(-102.01%↓ Y/Y)
Income from
unconsolidated joint venture
$255K
(16.97%↑ Y/Y)
Restructuring charges
-$46K
(-148.42%↓ Y/Y)
Canceled cashflow
$215,318K
Net increase
(decrease) in cash and cash...
$707K
(-43.17%↓ Y/Y)
Canceled cashflow
$305,410K
Payment of costs related
to issuance of...
$315K
Proceeds from sale of
marketable securities
$22,500K
(150.00%↑ Y/Y)
Accounts receivable, net
$10,650K
(7144.90%↑ Y/Y)
Other accrued
expenses
-$5,494K
(-316.81%↓ Y/Y)
Net loss
-$5,313K
(79.90%↑ Y/Y)
Other assets
$3,243K
(267.51%↑ Y/Y)
Prepaid expenses
$1,149K
(182.01%↑ Y/Y)
Lease liabilities
-$590K
(64.00%↑ Y/Y)
Inventory
$296K
(-44.26%↓ Y/Y)
Income from
unconsolidated joint venture
$15K
Deferred tax benefit
-$12K
(47.83%↑ Y/Y)
Income taxes payable
-$10K
(37.50%↑ Y/Y)
Canceled cashflow
$14,774K
Segment cost of revenue
$142,127K
(45.96%↑ Y/Y)
Segment adjusted
operating expense
$73,191K
(19.14%↑ Y/Y)
Net cash used in
investing activities
-$305,410K
(-206258.11%↓ Y/Y)
Canceled cashflow
$22,500K
Stock-based compensation
$11,346K
(43.71%↑ Y/Y)
Depreciation and
amortization
$5,836K
(29.83%↑ Y/Y)
Charitable contribution of
common stock
$1,811K
(194.95%↑ Y/Y)
Payroll tax expense
related to stock-based...
$459K
(75.86%↑ Y/Y)
(provision) benefit for
income taxes
$354K
(4525.00%↑ Y/Y)
Acquisition and other
$281K
(-58.43%↓ Y/Y)
Purchases of marketable
securities
$314,491K
(14412.74%↑ Y/Y)
Capitalization of software
development and purchases of...
$13,379K
Distributions in excess of
earnings
-$40K
(-122.22%↓ Y/Y)
Buy us a coffee